Partitioning, diffusivity and clearance of skin permeants in mammalian dermis

International Journal of Pharmaceutics

Volumn 346, Issue 1-2, 2008, Pages 64-79

  Kretsos, Kosmas ^a   Miller, Matthew A ^a   Zamora Estrada, Grettel ^a   Kasting, Gerald B ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

Author keywords

In silico prediction; Mathematical model; Percutaneous absorption; Skin; Topical delivery; Transdermal

Indexed keywords

BETAMETHASONE; BETAMETHASONE VALERATE; BUTANOL; CORTICOSTERONE; DECANOL; DEOXYCORTICOSTERONE; DIDANOSINE; GLUCOSE; HEPTANOL; HEXANOL; HYDROCORTISONE; HYPOXANTHINE ARABINOSIDE; METHANOL; METHOXSALEN; OCTANOL; PENTANOL; PIROXICAM; PROGESTERONE; PROGESTERONE DERIVATIVE; PROPANOL; RETINOIC ACID; SALICYLIC ACID; SERUM ALBUMIN; TESTOSTERONE; TESTOSTERONE H3; UNCLASSIFIED DRUG; VIDARABINE; VIDARABINE DERIVATIVE; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; DERMIS; DESORPTION; DIFFUSION; GUINEA PIG; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MAMMAL; MATHEMATICAL MODEL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SKIN; SKIN PERMEABILITY;

ANIMALS; CAPILLARY PERMEABILITY; DERMIS; DIFFUSION; GUINEA PIGS; HUMANS; MICE; MODELS, BIOLOGICAL; RATS; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SKIN ABSORPTION; TESTOSTERONE;

EID: 36048955468     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.06.020     Document Type: Article

References (77)

1. Allen J.G., and Bloxham D.P. The pharmacology and pharmacokinetics of the retinoids. Pharmac. Ther. 40 (1989) 1-27
2. Altshuler G., Smirnov M., and Yaroslavsky I. Lattice of optical islets: a novel treatment modality in photomedicine. J. Phys. D: Appl. Phys. 38 (2005) 2732-2747
3. Amsden B.G., and Goosen M.F.A. Transdermal delivery of peptide and protein drugs: an overview. AIChE J. 41 (1995) 1972-1997
4. Anigbogu A.N.C., Williams A.C., and Barry B.W. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment. J. Pharm. Pharmacol. 48 (1996) 357-366
5. Auton T.R., Westhead D.R., Woollen B.H., Scott R.C., and Wilks M.F. A physiologically based mathematical model of dermal absorption in man. Hum. Exp. Toxicol. 13 (1994) 51-60
6. Bashkatov A.N., Genina E.A., and Sinichkin Y.P. Glucose and mannitol diffusion in human dura mater. Biophys. J. 85 (2003) 3310-3318
7. Bauerova K., Matušová D., and Kassai Z. Chemical enhancers for transdermal drug transport. Eur. J. Drug Metab. Pharmacokinet. 26 (2001) 85-94
8. Benowitz N.L., Peyton J., Olsson P., and Johansson C.-J. Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow-limited percutaneous absorption. Clin. Pharmacol. Ther. 52 (1992) 223-230
9. Bert J.L., Mathieson J.M., and Pearce R.H. The exclusion of human serum albumin by human dermal collagenous fibres andd within human dermis. Biochem. J. 201 (1982) 395-403
10. Bert J.L., Pearce R.H., and Mathieson J.M. Concentration of plasma albumin in its accessible space in postmortem human dermis. Microvasc. Res. 32 (1986) 211-223
11. Bookout R.L., Quinn D.W., and McDougal J.N. Parallel dermal subcompartments for modeling chemical absorption. SAR QSAR Environ. Res. 7 (1997) 259-279
12. Borsadia S., Ghanem A.-H., Seta Y., Higuchi W.I., Flynn G.L., Behl C.R., and Shah V.P. Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations. Skin Pharmacol. 5 (1992) 129-145
13. Braverman I.M. The cutaneous microcirculation: ultrastructure and microanatomical organization. Microcirculation 4 (1997) 329-340
14. Cooper E.R. Effect of adsorption on membrane diffusion. J. Colloid Interface Sci. 48 (1974) 516-517
15. Cross S.E., Anissimov Y.G., Magnusson M., and Roberts M.S. Bovine-serum-albumin-containing receptor phase better predicts transdermal absorption parameters for lipophilic compounds. J. Invest. Dermatol. 120 (2003) 589-591
16. Cross S.E., Magnusson M., Winckle G., Anissimov Y.G., and Roberts M.S. Determination of the effect of lipophilicity on the in vitro permeability and tissue characteristics of topically applied solutes in human skin layers. J. Invest. Dermatol. 120 (2003) 759-764
17. Cross S.E., and Roberts M.S. Defining a model to predict the distribution of topically applied growth factors and other solutes in excisional full-thickness wounds. J. Invest. Dermatol. 112 (1999) 36-41
18. Cussler E.L. Diffusion: Mass Transfer in Fluid Systems (1997), Cambridge University Press, Cambridge
19. Dedrick R.L., Flessner M.F., Collins J.M., and Schultz J.S. Is the peritoneum a membrane?. ASAIO J. 5 (1982) 1-8
20. Dollery C. Therapeutic Drugs. second ed. (1999), Churchill Livingstone, Edinburgh
21. Florence A.T., and Attwood D. Physicochemical Principles of Pharmacy (2006), Pharmaceutical Press, London p. 77
22. Flynn G.L., and Stewart B. Percutaneous drug penetration: choosing candidates for transdermal development. Drug. Dev. Res. 13 (1988) 169-185
23. Gao X., Wientjes M.G., and Au J.L.-S. Use of drug kinetics in dermis to predict in vivo blood concentration after topical application. Pharm. Res. 12 (1995) 2012-2017
24. Gowrishankar T.R., Stewart D.A., Martin G.T., and Weaver J.C. Transport lattice models of heat transport in skin with spatially heterogeneous, temperature-dependent perfusion. Biomed. Eng. Online 3 (2004) 42
25. Gupta E., Wientjes M.G., and Au J.L.-S. Penetration kinetics of 2′-3′-dideoxyinosine in dermis is described by the distributed model. Pharm. Res. 12 (1995) 108-112
26. Guy R.H., Hadgraft J., and Maibach H.I. A pharmacokinetic model for percutaneous absorption. Int. J. Pharm. 11 (1982) 119-129
27. Higaki K., Asai M., Suyama T., Nakayama K., Ogawara K., and Kimura T. Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer. Int. J. Pharm. 239 (2002) 129-141
28. Hueber F., Wepierre J., and Schaefer H. Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacol. 5 (1992) 99-107
29. Joshi A., and Raje J. Sonicated transdermal drug transport. J. Control. Rel. 83 (2002) 13-22
30. Kammerau B., Zesch A., and Schaefer H. Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. J. Invest. Dermatol. 64 (1975) 145-149
31. Kammerau B., Klebe U., Zesch A., and Schaefer H. Penetration, permeation and resorption of 8-methoxypsoralen. Comparative in vitro and in vivo studies after topical application of four standard preparations. Arch. Dermatol. Res. 255 (1976) 31-42
32. Kasting G.B., and Bowman L.A. DC electrical properties of frozen, excised human skin. Pharm. Res. 7 (1990) 134-143
33. Kasting G.B., Barai N.D., Wang T.-F., and Nitsche J.M. Mobility of water in human stratum corneum. J. Pharm. Sci. 92 (2003) 2326-2340
34. Khalil E., Kretsos K., and Kasting G.B. Glucose partition coefficient and diffusivity in the lower skin layers. Pharm. Res. 23 (2006) 1227-1234
35. Kimber I., Gerberick G.F., and Basketter D.A. Thresholds in contact sensitization: theoretical and practical considerations. Food Chem. Toxicol. 37 (1999) 553-560
36. Kratochwil N.A., Huber W., Muller F., Kansy M., and Gerber P.R. Predicting plasma protein binding of drugs: a new approach. Biochem. Pharmacol. 64 (2002) 1355-1374
37. Kretsos, K., 2003. Transport phenomena in the human skin. Ph.D. Thesis. State University of New York at Buffalo, USA.
38. Kretsos K., Kasting G.B., and Nitsche J.M. Distributed diffusion-clearance model for transient drug distribution within the skin. J. Pharm. Sci. 93 (2004) 2820-2835
39. Kretsos K., and Kasting G.B. Dermal capillary clearance: physiology and modeling. Skin Pharmacol. Physiol. 18 (2005) 55-74
40. Kretsos K., and Kasting G.B. A geometrical model of dermal capillary clearance. Math. Biosci. 208 (2007) 430-453
41. Kubota K., and Maibach H.I. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate. J. Pharm. Sci. 82 (1993) 1039-1045
42. Kubota K., and Maibach H.I. Significance of viable skin layers in percutaneous permeation and its implication in mathematical models: theoretical consideration based on parameters for betamethasone 17-valerate. J. Pharm. Sci. 83 (1994) 1300-1306
43. Lee C.M., and Maibach H.I. Deep percutaneous penetration into muscles and joints. J. Pharm. Sci. 95 (2006) 1405-1413
44. McCarley K.D., and Bunge A.L. Pharmacokinetic models of dermal absorption. J. Pharm. Sci. 90 (2001) 1699-1718
45. In: Moffat A.C., Osselton M.D., and Widdop B. (Eds). Clarke's Analysis of Drugs and Poisons. third ed. (2003), Pharmaceutical Press, London
46. Monteiro-Riviere N.A., Bristol D.G., Manning T.O., Rogers R.A., and Riviere J.E. Interspecies and interregional analysis of the comparative histologic thickness and laser doppler blood flow measurements at five cutaneous sites in nine species. J. Invest. Dermatol. 95 (1990) 582-586
47. Monteiro-Riviere N.A., Inman A.O., Riviere J.E., McNeill S.C., and Francoeur M.L. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharm. Res. 10 (1993) 1326-1331
48. Pearce R.H., and Grimmer B.J. Age and the chemical constitution of normal human dermis. J. Invest. Dermatol. 58 (1972) 347-361
49. Pibouin M., Zini R., Nguyen P., Renouard A., and Tillement J.P. Binding of methoxypsoralen to human serum proteins and red blood cells. Brit. J. Dermatol. 117 (1987) 207-215
50. Poling B.E., Prausnitz J.M., and O'Connell J.P. The Properties of Gases and Liquids. fifth ed. (2001), McGraw Hill, New York
51. Potts R.O., and Guy R.H. Predicting skin permeability. Pharm. Res. 9 (1992) 663-669
52. Riviere J.E., and Heit M.C. Electrically-assisted transdermal drug delivery. Pharm. Res. 14 (1997) 687-697
53. Roberts M.S., and Cross S.E. A physiological pharmacokinetic model for solute disposition in tissues below a topical application site. Pharm. Res. 16 (1999) 1392-1398
54. Roberts M.S., and Walters K.A. The relationship between structure and barrier function in skin. In: Roberts M.S., and Walters K.A. (Eds). Dermal Absorption and Toxicity Assessment (1998), Marcel Dekker, New York 1-42
55. Schaefer H., and Zesch A. Penetration of vitamin A acid into human skin. Acta Derm. Venereol. Suppl. (Stockh.) 74 (1975) 50-55
56. Schaefer H., Stuttgen G., Zesch A., Schalla W., and Gazith J. Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr. Probl. Dermatol. 7 (1978) 80-94
57. Scheuplein R.J., and Blank I.H. Mechanism of percutaneous absorption.IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 60 (1973) 286-296
58. Scheuplein R.J. Skin permeation. In: Jarrett A. (Ed). The Physiology and Pathophysiology of the Skin vol. 5 (1978), Academic Press, London 1693-1730
59. Scheuplein R.J., and Bronaugh R.L. Percutaneous absorption. In: Goldsmith L.A. (Ed). Biochemistry and Physiology of the Skin vol. II (1983), Oxford University Press, New York 1255-1295
60. Shah J.C. Application of kinetic model to in vitro percutaneous permeation of drugs. Int. J. Pharm. 133 (1996) 179-189
61. Siegenthaler G., and Saurat J.-H. Retinoid binding proteins and human skin. Pharmacol. Therapeut. 40 (1989) 45-54
62. Siddiqui O., Roberts M.S., and Polack A.E. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J. Pharm. Biopharm. 17 (1989) 405-424
63. Singh P., and Roberts M.S. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J. Pharmacokinet. Biopharm. 21 (1993) 337-373
64. Singh P., and Roberts M.S. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J. Pharm. Sci. 82 (1993) 127-131
65. Singh P., and Roberts M.S. Local deep tissue penetration of compounds after dermal application: Structure-tissue penetration relationships. J. Pharmacol. Exp. Ther. 279 (1996) 908-917
66. Sommer A., Lucassen G.W., Houben A.J.H.M., and Neumann M.H.A. Vasoconstrictive effect of topical applied corticosteroids measured by laser Doppler imaging and reflectance spectroscopy. Microvasc. Res. 65 (2003) 152-159
67. Takino T., Nakajima C., Takakura Y., Sezaki H., and Hashida M. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. J. Drug Target 1 (1993) 117-124
68. Tojo K., Chiang C.C., and Chien Y.W. Drug permeation across the skin: effect of penetrant hydrophilicity. J. Pharm. Sci. 76 (1987) 123-126
69. Wagner H., Kostka K.-H., Lehr C.-M., and Schaefer U.M. Human skin penetration of flufenamic acid: In vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject. J. Invest. Dermatol. 118 (2002) 540-544
70. Wang T.-F., Kasting G.B., and Nitsche J.M. A multiphase microscopic model for stratum corneum permeability. I. Formulation, solution and illustrative results for representative compounds. J. Pharm. Sci. 95 (2006) 620-648
71. Wang, T.-F., Kasting, G.B., Nitsche, J.M., 2007. A multiphase microscopic model for stratum corneum permeability. II. Estimation of physicochemical parameters and application to a large permeability database. J. Pharm. Sci., doi:10.1002/jps_2007, in press.
72. Wheeler M.J. The determination of bio-available testosterone. Ann. Clin. Biochem. 32 (1995) 345-357
73. Wiig H., Kolmannskog O., Tenstad O., and Bert J.L. Effect of charge on interstitial distribution of albumin in rat dermis in vitro. J. Physiol. 550 (2003) 505-514
74. Yamazaki K., and Kanaoka M. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds. J. Pharm. Sci. 93 (2004) 1480-1494
75. Yu C.D., Fox J.L., Ho N.F.H., and Higuchi W.I. Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5′-valerate II: parameter determinations. J. Pharm. Sci. 68 (1979) 1347-1357
76. Yu C.D., Higuchi W.I., Ho N.F.H., Fox J.L., and Flynn G.L. Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5′-valerate III: permeability differences of vidarabine and n-pentanol in components of hairless mouse skin. J. Pharm. Sci. 69 (1980) 770-772
77. Zesch A., and Schaefer H. Penetrationskinetik von radiomarkiertem hydrocortisone aus verschiedenartigen salbengrundlagen in die menschliche haut. Arch. Dermatol. Res. 252 (1975) 245-256